Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Conox-Guided Anesthesia in Pediatric Adenotonsillectomy

NCT: NCT07577154 · RECRUITING

NCT IDNCT07577154
StatusRECRUITING
Start Date2026-03-01
Completion2026-09-01

Brief Summary

This study aims to evaluate the effect of Conox (qCON/qNOX)-guided anesthesia on intraoperative anesthetic drug consumption and postoperative outcomes in pediatric patients undergoing adenotonsillectomy. Conox is a non-invasive EEG-based monitoring system that provides indices of both hypnosis and nociception. In this randomized controlled trial, children aged 3-12 years will be assigned to either a Conox-guided anesthesia group or a standard monitoring group. The primary outcome of the study is total intraoperative opioid consumption, assessed from anesthesia induction to the end of surgery. Secondary outcomes include emergence time, extubation time, postoperative agitation, pain scores, and correlation between qCON/qNOX values and hemodynamic parameters.

Frequently Asked Questions

What is Conox-Guided Anesthesia in Pediatric Adenotonsillectomy?

Conox-Guided Anesthesia in Pediatric Adenotonsillectomy is a clinical trial registered under NCT07577154. Current status: RECRUITING.

What is the status of NCT07577154?

The current status of NCT07577154 (Conox-Guided Anesthesia in Pediatric Adenotonsillectomy) is: RECRUITING.

When did Conox-Guided Anesthesia in Pediatric Adenotonsillectomy start?

Conox-Guided Anesthesia in Pediatric Adenotonsillectomy started on 2026-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.